Ionis Pharmaceuticals's total assets for Q1 2025 were $2.81B, a decrease of -6.35% from the previous quarter. IONS total liabilities were $2.34B for the fiscal quarter, a -3.23% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.